Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-21,400
Closed -$647K 4338
2025
Q4
$647K Sell
21,400
-10,200
-32% -$250K ﹤0.01% 2991
2025
Q3
$626K Buy
31,600
+10,000
+46% +$209K ﹤0.01% 3058
2025
Q2
$538K Buy
21,600
+8,000
+59% +$180K ﹤0.01% 3205
2025
Q1
$319K Sell
13,600
-30,500
-69% -$883K ﹤0.01% 3697
2024
Q4
$1.23M Sell
44,100
-234,800
-84% -$6.29M ﹤0.01% 2860
2024
Q3
$5.68M Sell
278,900
-64,300
-19% -$1.44M 0.01% 1336
2024
Q2
$10.1M Sell
343,200
-48,700
-12% -$1.4M 0.02% 942
2024
Q1
$12M Buy
391,900
+165,000
+73% +$4.66M 0.02% 886
2023
Q4
$5.31M Buy
226,900
+46,500
+26% +$1.12M 0.01% 1354
2023
Q3
$5.34M Buy
+180,400
New +$6.05M 0.01% 1134

Other funds holding CFLT

Squarepoint's CFLT Position: Q1 2026 in Review

Squarepoint sold out of Confluent (CFLT) in Q1 2026, closing a stake of 1,454,703 shares — an estimated $44M sold.

Squarepoint first reported a position in CFLT in Q2 2021 and held it in 12 quarters. The position peaked at $83.2M in Q2 2025. 4 funds tracked by Wall St. Rank hold CFLT as of Q1 2026.

  • Squarepoint reported no remaining Confluent position as of Q1 2026 after selling out during the quarter.
  • Squarepoint sold 1,454,703 Confluent shares in Q1 2026, an estimated $44M.
  • Squarepoint first reported a position in Confluent in Q2 2021 and held it in 12 quarters.
  • Squarepoint's Confluent position peaked at $83.2M in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Confluent as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.